Mosaic Biosciences’ Post

Have you already found all the antibody pins? Meet one of our antibody experts at #PEGSEurope in this last day of conference and ask for yours. Grab them all and graduate to the ultimate level of #antibodyexpertise! #antibodydiscovery #biologics #biotech #antibodies

Achieving consistent production of biological therapeutics presents distinctive challenges in bioanalysis. Find out how we addressed these challenges and ensured superior sensitivity in this poster presentation: https://lnkd.in/gH98pK5a #DrugDevelopment #Biologics #LifeSciences

🚨 Last chance to meet David Muñoz at Swiss Biotech Day! 🚨 Today's the final day of the conference, and we are eager to connect with you. Don't miss out on the opportunity to discuss biotech innovations and potential collaborations. 📧 Send directly a message to David Muñoz to schedule a meeting. See you there! #Biotech #CDMO #SwissBiotechDay #Biopharmaceuticals #Biologics #3PBIOVIAN Swiss Biotech Association

Scale up your industry knowledge at the European Biomanufacturing Summit on 10-11 September 2024 in Berlin, Germany. Immerse yourself with over 120 biomanufacturing experts in lively discussions on biomanufacturing #cellandgene #biologics and #biosimilars, along with many other core discussions in the industry. Stay at the forefront of industry trends and connect with top innovators in the #biomanufacturing industry https://hubs.ly/Q02C1N8k0 #BioEU24 #GenerisBIOEU

Our founding Chief Scientific Officer, Prof. Wayne Reed, is presenting next Monday at the American Chemical Society's Spring 2024 conference in New Orleans. Prof. Reed will discuss new data that stems from the continuous, real-time monitoring of non-equilibrium processes during the development of biologic products. #biotech #biopharmaceutical #analytics #data #biologics

Roundtable sessions have begun! Some brilliant discussions led by key players in biologic drug development, covering a wide breadth of topics! #festivalofbiologics #roundtable #biologics

Don't miss out on this exciting presentation at ACS where Prof. Wayne Reed will discuss new data arising from the continuous, real-time monitoring of non-equilibrium processes during the development of biologic products. #biotech #biopharmaceutical #analytics #data #biologics

It is the first day of #Biologics 2024! We are excited to learn more about biologics and how AI can be integrated into the discovery workflow to predict structures, developability and affinity - ultimately improving lead optimization Oxford Global

Curious about Abzena's new, high-producing cell line development platforms- AbZelect™ & AbZelectPRO™? Check out our latest blog to find out how our unique CLD platforms are increasing efficiencies while reducing risks and costs for early-phase biologic and bioconjugate drug programs.

Protein A is the darling of downstream unit operations for the manufacture of monoclonal antibodies. Its numerous advantages far outweighs its disadvantages and dispite its high cost it has become the resin of choice for the initial capture step in the purification platform for Mabs. Abzena’s platform for Mabs includes Protein A as the capture step. Other affinity resins are now available if the product of interest is not a Mab. Affinity chromatography has come a long way since the introduction of protein A. To find out more take a few minutes to read the article attached. Stay healthy and well Abzena